Aller au contenu principal
Profil bibliographique

Alexander Leach

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

3Publications signalées
14Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Respiratory viral infections researchHIV Research and TreatmentMosquito-borne diseases and controlNeonatal Respiratory Health ResearchViral Infections and Immunology Research

Les publications récentes

Accès ouvert 2026 article OpenAlex

Identification and characterization of novel chikungunya virus polymerase inhibitors

Peiqi Yin, Sainan Wang, Michael R. Sirrine, Alexander Leach et autres

ABSTRACT Chikungunya virus (CHIKV) and other alphaviruses in the Togaviridae family are positive-sense RNA viruses and major human pathogens, causing millions of infections worldwide. In humans, alphaviruses such as CHIKV, Mayaro and Ross River viruses typically cause arthritogenic disease characterized by debilitating …

us, ee (code pays fourni par la source)

0 citations Journal of Virology
Accès ouvert 2025 preprint OpenAlex

Developmental candidate GHP-88310/EIDD-3608 with high tolerability and oral efficacy in measles and respiratory paramyxovirus models

Carolin M. Lieber, Josef D. Wolf, Mugunthan Govindarajan, Jeong_Joong Yoon et autres

Orthoparamyxoviruses such as human parainfluenza virus type-3 (HPIV3), measles virus (MeV), and emerging henipaviruses pose a substantial threat to human health. We discovered an orally efficacious broad-spectrum non-nucleoside inhibitor of orthoparamyxovirus polymerases. However, here we found that tolerability in higher mammals was …

us (code pays fourni par la source)

0 citations bioRxiv (Cold Spring Harbor Laboratory)
2022 article OpenAlex

Nirsevimab for Prevention of RSV in Healthy Late-preterm and Term Infants

L.L. Hammitt, R. Dagan, Y. Yuan, M. Baca Cots et autres

(N Engl J Med. 2022;386:837–846. doi: 10.1056/NEJMoa2110275) Infants experience medically attended illness and hospitalization at elevated rates from respiratory syncytial virus (RSV) infection. As a monoclonal antibody with an extended half-life, Nirsevimab (N) is an emerging treatment that binds to the RSV …

us (code pays fourni par la source)

14 citations Obstetric Anesthesia Digest

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.